Angioimmunoblastic T-Cell Lymphoma after Treatment of Classic Hodgkin Lymphoma: A Case Report

We report a case of a 24-year-old man who developed angioimmunoblastic T-cell lymphoma (AITL) after treatment for refractory lymphocyte-rich classic Hodgkin lymphoma (LR-CHL). This patient was treated with the BV+AVD (brentuximab vedotin, doxorubicin, vinblastine, and dacarbazine) protocol for LR-CH...

Full description

Bibliographic Details

Published in:	Hematology Reports
Main Authors:	Ken Tanaka, Hiroaki Miyoshi, Yusuke Yamashita, Ryuta Iwamoto, Yuma Yokoya, Yuichi Tochino, Fumiko Arakawa, Shinobu Tamura, Shin-Ichi Murata, Takashi Sonoki, Koichi Ohshima
Format:	Article
Language:	English
Published:	MDPI AG 2023-11-01
Subjects:	classic hodgkin lymphoma lymphocyte rich classic hodgkin lymphoma angioimmunoblastic T-cell lymphoma secondary non-hodgkin lymphoma
Online Access:	https://www.mdpi.com/2038-8330/15/4/67